source
- Novo claims 80% share of oral GLP-1 market as rivalry with Lilly intensifiesNovo's CEO Mike Maziar Doustdar said the company leads the oral GLP-1 market, stating the Wegovy pill holds about 80% of prescriptions since its launch in January. Eli Lilly, however, reported tha…
- Democrats win Congress and doctors secure key seats, shifting health policy directionThe recent midterm elections gave Democrats control of both the House and the Senate. Voters also elected a number of doctors and scientists to key congressional positions. These outcomes signal a…